Literature DB >> 11429488

Predictive and prognostic markers in gastrointestinal cancers.

C G Leichman1.   

Abstract

As the roles of specific genes and their functions in cancer etiology and progression become defined, the necessity of looking at multiple genes and their interaction becomes clearer. In gastrointestinal cancer, tumor suppressor and promoter genes, cell cycle control and angiogenic factors, repair genes, and metabolic genes have been examined as they relate to prognosis and therapeutic outcomes. To date, most correlative studies for specific molecular parameters have been done retrospectively. Methodologies, sample sizes, and definitions differ. The following analysis provides a brief review of the current state of knowledge and recent research on the most commonly studied molecular markers, and the newer areas of inquiry attempting to define how to use molecular-genetic features of individual tumors as targets for more effective therapies. Consideration is given to the design of trials employing molecular targets as outcome factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429488     DOI: 10.1097/00001622-200107000-00013

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  6 in total

Review 1.  Metabolic genes in cancer: their roles in tumor progression and clinical implications.

Authors:  Eiji Furuta; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2010-02-01

Review 2.  [Current status of the prognostic value of molecular markers in patients with colorectal cancer and the prediction of response to adjuvant therapy].

Authors:  Jose M Fernández-Cebrián; Peter Vorwald Kuborn; Mar Pardo de Lama; Alfonso Sanjuanbenito Dehesa; Manuel Nevado Santos; Pedro A Pacheco Martínez; Beatriz Fernández-Escudero
Journal:  Clin Transl Oncol       Date:  2005-04       Impact factor: 3.405

3.  Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase.

Authors:  Jing Li; Seongho Kim; Anthony F Shields; Kirk A Douglas; Christopher I McHugh; Jawana M Lawhorn-Crews; Jianmei Wu; Thomas J Mangner; Patricia M LoRusso
Journal:  J Clin Pharmacol       Date:  2016-11       Impact factor: 3.126

4.  Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.

Authors:  Y J Fang; Z H Lu; G Q Wang; Z Z Pan; Z W Zhou; J P Yun; M F Zhang; D S Wan
Journal:  Int J Colorectal Dis       Date:  2009-05-07       Impact factor: 2.571

5.  Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.

Authors:  Kazuki Sakamoto; Tatsushi Yokogawa; Hiroyuki Ueno; Kei Oguchi; Hiromi Kazuno; Keiji Ishida; Nozomu Tanaka; Akiko Osada; Yukari Yamada; Hiroyuki Okabe; Kenichi Matsuo
Journal:  Int J Oncol       Date:  2015-04-20       Impact factor: 5.650

6.  Clinicopathological analysis of factors related to colorectal tumor perforation: influence of angiogenesis.

Authors:  Vicente Medina-Arana; Antonio Martínez-Riera; Luciano Delgado-Plasencia; Diana Rodríguez-González; Alberto Bravo-Gutiérrez; Hugo Álvarez-Argüelles; Antonio Alarcó-Hernández; Eduardo Salido-Ruiz; Antonia M Fernández-Peralta; Juan J González-Aguilera
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.